top of page
Executive Spotlights

Pfizer snaps up Seagen for $43 bln as Drugmaker extends buying spree

New York, NY, March 13, 2023 (Reuters) -- Pfizer Inc struck a $43 billion deal to buy Seagen Inc in the U.S. drugmaker's biggest in a string of acquisitions undertaken after a sales windfall from its COVID-19 products.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page